| Fiscal Period | 2025 | 2024 | 2023 |
|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | -0.16 | -0.24 | -0.26 |
| Net Changein Cash | 0.27 | 0.00 | 0.01 |
| Cash Taxes Paid | 0.01 | 0.02 | 0.02 |
| Net Income/ Starting Line | 0.09 | 0.06 | 0.05 |
| Changesin Working Capital | -0.45 | -1.32 | -0.04 |
| Cashfrom Operating Activities | -0.58 | -1.26 | -0.04 |
| Cash Interest Paid | 0.17 | 0.18 | 0.19 |
| Cashfrom Financing Activities | -0.33 | 1.14 | -0.44 |
| Issuance( Retirement)of Stock Net | 0.00 | 1.56 | - |
| Depreciation/ Depletion | 0.05 | 0.05 | 0.06 |
| Other Investing Cash Flow Items Total | 1.28 | 0.15 | 0.51 |
| Capital Expenditures | -0.10 | -0.02 | -0.01 |
| period Type | - | - | - |
| Non- Cash Items | -0.27 | -0.06 | -0.11 |
| Financing Cash Flow Items | -0.17 | -0.18 | -0.19 |
| period Length | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | 1.18 | 0.13 | 0.49 |
Ganga Pharmaceuticals Dividend Ganga Pharmaceuticals Bonus Ganga Pharmaceuticals News Ganga Pharmaceuticals AGM Ganga Pharmaceuticals Rights Ganga Pharmaceuticals Splits Ganga Pharmaceuticals Board Meetings Ganga Pharmaceuticals Key Metrics Ganga Pharmaceuticals Shareholdings Ganga Pharmaceuticals Profit Loss Ganga Pharmaceuticals Balance Sheet Ganga Pharmaceuticals Q1 Results Ganga Pharmaceuticals Q2 Results Ganga Pharmaceuticals Q3 Results Ganga Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks